Expression of antibody–drug conjugate targets in soft tissue sarcomas
Article 2025 en
Authors
FB
François Bertucci
PF
Pascal Finetti
LM
Lénaïg Mescam
Abstract
1 min read
STSs express multiple target genes relevant for ADC treatment and expression varies between and within the pathological types. This comprehensive ADC target landscape, based on the largest molecular epidemiology study in STS, should help clinicians and drug developers for further evaluation of ADCs across STS types.
Kwan Woo Lee, S. Kim, Hye-Jin Hong, Eunjeong Park, Jungok Park, Seongho Hong, Daekwon Bae, Nina Ha, Sohn-Ji Yeon, Inchang Hwang, Se‐Mi Kim, Yoonseok Lee, Ju‐Hee Lee
Sandro Pasquali, Chiara Castelli, Paola Collini, Marta Barisella, Cleofé Romagosa, Sílvia Bagué, Jean Michel Coindre, Paolo De Tos, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Jean Yves Blay, Robert Díaz Beveridge, Domenico Franco Merlo, Silvia Stacchiotti, Paolo G. Casali, Alessandro Gronchi
Elise F. Nassif, Jean Yves Blay, Christophe Massard, Armelle Dufresne, Mehdi Brahmi, Philippe A. Cassier, Isabelle Ray‐Coquard, Patricia Pautier, Alexandra Léary, M.-P. Sunyach, Rastislav Bahleda, Antonin Lévy, C. Le Péchoux, Charles Honoré, Olivier Mir, Axel Le Cesne
Amanda R. Dancsok, Dongxia Gao, Anna F. Lee, Sonja E. Steigen, Jean Yves Blay, David M. Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco
Discussion(0)
No comments yet. Be the first to comment.